Akso Health Group current report, Q1 FY2019

SEC Filing Summary: Hexindai Inc. (Form 6-K)

Business Context and Reporting Period

This Form 6-K was filed by Hexindai Inc., a foreign private issuer, for the month of January 2019. The report was signed by Zhang Qisen (Johnson), Chief Financial Officer, on January 11, 2019. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing serves as a report pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document consists of the cover page, signature block, and an exhibit index referencing a press release (Exhibit 99.1), but the financial data within that press release is not included in the provided text.

Material Changes

The filing text does not provide a clear value regarding material changes versus the prior comparable period. No comparative financial data or operational updates are present in the provided content.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document does not contain the body of the press release referenced in the exhibit index where such information would typically be disclosed.

Key Facts for Investor Verification

  • The filing is a Form 6-K dated January 11, 2019, for Hexindai Inc.
  • The document references a Press Release (Exhibit 99.1) but does not contain the text of that release.
  • No specific financial figures or operational metrics are disclosed in the provided text.
  • Investors must locate and review the full text of Exhibit 99.1 to obtain the actual announcement details.